The Centers for Disease Control & Prevention describes fibromyalgia as a disorder characterized by widespread bodily pain, sleep disturbances, fatigue, and often emotional and mental distress. Individuals with fibromyalgia tend to have a heightened sensitivity to pain, a phenomenon known as abnormal pain perception processing. Approximately 4 million adults in the U.S., or about 2% of the adult population, suffer from this condition.

The exact causes of fibromyalgia remain unclear, but it can be effectively managed with treatment. Although there are various treatment options available, none are specifically approved for fibromyalgia and they primarily aim to alleviate symptoms rather than address the root cause.

Hyperbaric therapy, which involves exposing the body to higher levels of oxygen in a pressurized environment, has shown promise in significantly reducing inflammation. This therapy increases oxygen delivery via the plasma, leading to decreased inflammation and pain in the body.